SK281899B6 - Bicyklické peptidy, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents

Bicyklické peptidy, farmaceutický prostriedok s ich obsahom a ich použitie Download PDF

Info

Publication number
SK281899B6
SK281899B6 SK1212-97A SK121297A SK281899B6 SK 281899 B6 SK281899 B6 SK 281899B6 SK 121297 A SK121297 A SK 121297A SK 281899 B6 SK281899 B6 SK 281899B6
Authority
SK
Slovakia
Prior art keywords
cyclo
dap
asp
leu
seq
Prior art date
Application number
SK1212-97A
Other languages
English (en)
Slovak (sk)
Other versions
SK121297A3 (en
Inventor
Federico Arcamone
Carlo Alberto Maggi
Laura Quartara
Danilo Giannotti
Original Assignee
A. Menarini Industrie Farmaceutiche Riunite S. R. L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11351134&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK281899(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by A. Menarini Industrie Farmaceutiche Riunite S. R. L. filed Critical A. Menarini Industrie Farmaceutiche Riunite S. R. L.
Publication of SK121297A3 publication Critical patent/SK121297A3/sk
Publication of SK281899B6 publication Critical patent/SK281899B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SK1212-97A 1995-03-13 1996-03-11 Bicyklické peptidy, farmaceutický prostriedok s ich obsahom a ich použitie SK281899B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95FI000044A IT1277835B1 (it) 1995-03-13 1995-03-13 Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche
PCT/EP1996/001028 WO1996028467A1 (en) 1995-03-13 1996-03-11 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition

Publications (2)

Publication Number Publication Date
SK121297A3 SK121297A3 (en) 1998-02-04
SK281899B6 true SK281899B6 (sk) 2001-09-11

Family

ID=11351134

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1212-97A SK281899B6 (sk) 1995-03-13 1996-03-11 Bicyklické peptidy, farmaceutický prostriedok s ich obsahom a ich použitie

Country Status (33)

Country Link
US (1) US6150325A (es)
EP (1) EP0815126B1 (es)
JP (1) JP4618821B2 (es)
KR (1) KR100405009B1 (es)
CN (1) CN1189477C (es)
AR (1) AR004476A1 (es)
AT (1) ATE198481T1 (es)
AU (1) AU696528B2 (es)
BG (1) BG63208B1 (es)
BR (1) BR9607348A (es)
CZ (1) CZ287372B6 (es)
DE (1) DE69611438T2 (es)
DK (1) DK0815126T3 (es)
EA (1) EA000697B1 (es)
EE (1) EE03618B1 (es)
ES (1) ES2155187T3 (es)
GE (1) GEP20002271B (es)
GR (1) GR3035676T3 (es)
HR (1) HRP960117B1 (es)
HU (1) HU222051B1 (es)
IL (1) IL117395A (es)
IT (1) IT1277835B1 (es)
MX (1) MX9706927A (es)
NO (1) NO319290B1 (es)
NZ (1) NZ303982A (es)
PL (1) PL184147B1 (es)
PT (1) PT815126E (es)
RO (1) RO118297B1 (es)
SK (1) SK281899B6 (es)
TW (1) TW565572B (es)
UA (1) UA48962C2 (es)
WO (1) WO1996028467A1 (es)
ZA (1) ZA961983B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017705A (en) * 1995-03-14 2000-01-25 Ludwig Institute For Cancer Research Isolated nucleic acid molecules which are members of the MAGE-B family and uses thereof
IT1291776B1 (it) * 1997-02-07 1999-01-21 Menarini Ricerche Spa Composti monociclici a quattro residui bifunzionali, aventi azione nk-2 antagonista
IT1304888B1 (it) * 1998-08-05 2001-04-05 Menarini Ricerche Spa Composti monociclici ad azione nk-2 antagonista e formulazioni che licontengono
NZ523310A (en) * 2000-06-12 2005-07-29 Univ Rochester Tachykinin receptor antagonist to block receptors NK1, NK2, and NK3 and treat symptoms of hormonal variation
EP1297826A1 (en) * 2001-09-27 2003-04-02 Menarini Ricerche S.p.A. Nasal pharmaceutical compositions containing a NK-2 antagonist
ITFI20020239A1 (it) 2002-12-06 2004-06-07 Menarini Ricerche Spa Processo per la preparazione di composti peptidici biciclici.
ITFI20040221A1 (it) * 2004-10-27 2005-01-27 Guidotti & C Spa Composizioni farmaceutiche a base di nk2 antagonisti per uso pediatrico
ITRM20120331A1 (it) 2012-07-12 2014-01-13 Guidotti & C Spa Labor Composizioni pediatriche orali liquide contenenti nepadutant.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1262902B (it) * 1992-04-15 1996-07-22 Menarini Farma Ind Composti triciclici antagonisti delle tachichinine, loro preparazione e loro uso in composizioni farmaceutiche.

Also Published As

Publication number Publication date
GEP20002271B (en) 2000-10-25
EE03618B1 (et) 2002-02-15
CZ287372B6 (en) 2000-11-15
HRP960117A2 (en) 1997-08-31
KR100405009B1 (ko) 2004-05-20
PL322105A1 (en) 1998-01-05
SK121297A3 (en) 1998-02-04
EP0815126B1 (en) 2001-01-03
AU696528B2 (en) 1998-09-10
ITFI950044A1 (it) 1996-09-13
CN1183786A (zh) 1998-06-03
DE69611438D1 (de) 2001-02-08
ES2155187T3 (es) 2001-05-01
WO1996028467A1 (en) 1996-09-19
EE9700230A (et) 1998-04-15
NO974057L (no) 1997-11-07
ATE198481T1 (de) 2001-01-15
HUP9801835A3 (en) 2000-05-29
MX9706927A (es) 1997-11-29
HUP9801835A2 (hu) 1999-01-28
KR19980703011A (ko) 1998-09-05
ITFI950044A0 (it) 1995-03-13
EA199700223A1 (ru) 1998-04-30
JP4618821B2 (ja) 2011-01-26
HRP960117B1 (en) 2001-06-30
PT815126E (pt) 2001-06-29
BG101849A (en) 1998-04-30
CN1189477C (zh) 2005-02-16
DE69611438T2 (de) 2001-06-13
DK0815126T3 (da) 2001-05-07
IL117395A0 (en) 1996-07-23
AR004476A1 (es) 1998-12-16
EP0815126A1 (en) 1998-01-07
IT1277835B1 (it) 1997-11-12
CZ286297A3 (cs) 1998-02-18
US6150325A (en) 2000-11-21
GR3035676T3 (en) 2001-06-29
RO118297B1 (ro) 2003-04-30
NO319290B1 (no) 2005-07-11
HU222051B1 (hu) 2003-04-28
TW565572B (en) 2003-12-11
JPH11501643A (ja) 1999-02-09
NO974057D0 (no) 1997-09-03
BR9607348A (pt) 1997-12-30
PL184147B1 (pl) 2002-09-30
NZ303982A (en) 1998-04-27
BG63208B1 (bg) 2001-06-29
AU5105996A (en) 1996-10-02
EA000697B1 (ru) 2000-02-28
IL117395A (en) 1999-12-31
UA48962C2 (uk) 2002-09-16
ZA961983B (en) 1997-09-29

Similar Documents

Publication Publication Date Title
KR100351213B1 (ko) 펩타이드 부갑상선 호르몬 유사체 및 이를 포함하는 약제학적 조성물
AU638606B2 (en) Novel polypeptide and anti-hiv drug prepared therefrom
SK281899B6 (sk) Bicyklické peptidy, farmaceutický prostriedok s ich obsahom a ich použitie
AU619573B2 (en) Irreversible peptide ligands for bombesin receptors
US5731285A (en) Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
AU671118B2 (en) Tachykinin antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
CA2405724C (en) Substance p analogs for the treatment of cancer
US6596692B1 (en) Substance P analogs for the treatment of cancer
EP0452447A1 (en) Reduced irreversible bombesin antagonists
US5786447A (en) Opioid peptide analogs
CA2215372C (en) Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition
KR100630489B1 (ko) 면역반응을 조절하는 펩타이드

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20160311